Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring PRRC2B-ALK Rearrangement: A Case Report

Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm and patients with IMT tend to have a favorable outcome after complete surgical resection. However, some tumors of IMT cases have recurred and grown rapidly after successful surgery. Epithelioid inflammatory myofibroblastic sarco...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhan, Geng, Yan, Yuan, Ling-Yan, Wang, Miao-Miao, Ye, Chen-Yang, Sun, Li, Dai, Wei-Ping, Zang, Yuan-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882834/
https://www.ncbi.nlm.nih.gov/pubmed/35237506
http://dx.doi.org/10.3389/fonc.2022.761558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882834/
https://www.ncbi.nlm.nih.gov/pubmed/35237506
http://dx.doi.org/10.3389/fonc.2022.761558

Ejemplares similares